- Home
- ASLE vs CADL Comparison
ASLE vs CADL Comparison
Compare ASLE & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASLE
- CADL
- Stock Information
- Founded
- ASLE 2008
- CADL 1999
- Country
- ASLE United States
- CADL United States
- Employees
- ASLE N/A
- CADL N/A
- Industry
- ASLE Industrial Specialties
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- ASLE Consumer Discretionary
- CADL Health Care
- Exchange
- ASLE Nasdaq
- CADL Nasdaq
- Market Cap
- ASLE 284.0M
- CADL 250.0M
- IPO Year
- ASLE N/A
- CADL 2021
- Fundamental
- Price
- ASLE $5.90
- CADL $5.81
- Analyst Decision
- ASLE Buy
- CADL Strong Buy
- Analyst Count
- ASLE 3
- CADL 5
- Target Price
- ASLE $8.00
- CADL $21.40
- AVG Volume (30 Days)
- ASLE 289.7K
- CADL 1.0M
- Earning Date
- ASLE 08-06-2025
- CADL 08-12-2025
- Dividend Yield
- ASLE N/A
- CADL N/A
- EPS Growth
- ASLE N/A
- CADL N/A
- EPS
- ASLE N/A
- CADL N/A
- Revenue
- ASLE $320,302,000.00
- CADL N/A
- Revenue This Year
- ASLE $2.54
- CADL N/A
- Revenue Next Year
- ASLE $16.24
- CADL N/A
- P/E Ratio
- ASLE N/A
- CADL N/A
- Revenue Growth
- ASLE N/A
- CADL N/A
- 52 Week Low
- ASLE $4.53
- CADL $3.79
- 52 Week High
- ASLE $8.76
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- ASLE 42.72
- CADL 58.86
- Support Level
- ASLE $6.00
- CADL $4.86
- Resistance Level
- ASLE $6.24
- CADL $6.42
- Average True Range (ATR)
- ASLE 0.16
- CADL 0.34
- MACD
- ASLE 0.02
- CADL 0.13
- Stochastic Oscillator
- ASLE 45.59
- CADL 68.56
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.